Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 4, 2009, Pages

  Stone, Shelley F ^a   Cotterell, Claire ^a   Isbister, Geoffrey K ^b,c   Holdgate, Anna ^d   Brown, Simon G A ^a,e  

^a ROYAL PERTH HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e FREMANTLE HOSPITAL   (Australia)

Author keywords

Anaphylaxis physiopathology; chemokines; cytokines; histamine; IL 10; IL 2; IL 6; mast cell tryptase; TNFRI

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; AGED; AIRWAY; ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; ASSAY; CHILD; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HUMAN; HYPOTENSION; HYPOXEMIA; HYPOXIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RATING SCALE; RESPIRATORY SYSTEM; ACUTE DISEASE; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; ANAPHYLAXIS; CYTOKINES; FEMALE; HISTAMINE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRYPTASES;

EID: 70449710916     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.07.055     Document Type: Article

References (24)

1. Ogawa Y., and Grant J.A. Mediators of anaphylaxis. Immunol Allergy Clin North Am 27 (2007) 249-260
2. Finkelman F.D. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 120 (2007) 506-515
3. Cornejo-Garcia J.A., Fernandez T.D., Torres M.J., Carballo M., Hernan I., Antunez C., et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 62 (2007) 1429-1438
4. Radermecker M., Louis R., Leclercq M., Weber T., Corhay J.L., and Bury T. Cytokine modulation of basophil histamine release in wasp-venom allergy. Allergy 49 (1994) 641-644
5. Knoops L., Louahed J., Van Snick J., and Renauld J.C. IL-9 promotes but is not necessary for systemic anaphylaxis. J Immunol 175 (2005) 335-341
6. van der Linden P.W., Hack C.E., Poortman J., Vivie-Kipp Y.C., Struyvenberg A., and van der Zwan J.K. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 90 (1992) 110-118
7. Lin R.Y., Schwartz L.B., Curry A., Persola G.R., Knight R.J., Lee H.S., et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 106 (2000) 65-71
8. Brown S.G.A. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114 (2004) 371-376
9. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 117 (2006) 391-397
10. Brown S.G.A., Blackman K.E., and Heddle R.J. Can serum mast cell tryptase help diagnose anaphylaxis?. Emerg Med Australas 16 (2004) 120-124
11. Strait R.T., Morris S.C., Smiley K., Urban J.F., and Finkelman F.D. IL-4 exacerbates anaphylaxis. J Immunol 170 (2003) 3835-3842
12. Fallon P.G., Emson C.L., Smith P., and McKenzie A.N.J. IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J Immunol 166 (2001) 2712-2717
13. Castells M. Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am 26 (2006) 465-485
14. Vadas P., Gold M., Perelman B., Liss G.M., Lack G., Blyth T., et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 358 (2008) 28-35
15. Ono E., Taniguchi M., Mita H., Fukutomi Y., Higashi N., Miyazaki E., et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy 39 (2009) 72-80
16. van der Linden P.W., Struyvenberg A., Kraaijenhagen R.J., Hack C.E., and van der Zwan J.K. Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med 118 (1993) 161-168
17. van der Linden P.W., Hack C.E., Struyvenberg A., Roem D., Brouwer M.C., de Boer J.P., et al. Controlled insect-sting challenge in 55 patients: correlation between activation of plasminogen and the development of anaphylactic shock. Blood 82 (1993) 1740-1748
18. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7 (1996) 231-240
19. Lin R.Y., Trivino M.R., Curry A., Pesola G.R., Knight R.J., Lee H.S., et al. Interleukin 6 and C-reactive protein levels in patients with acute allergic reactions: an emergency department-based study. Ann Allergy Asthma Immunol 87 (2001) 412-416
20. Tousoulis D., Davies G., Stefanadis C., Toutouzas P., and Ambrose J. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 89 (2003) 993-997
21. Conti P., Kempuraj D., Di Gioacchino M., Boucher W., Letourneau R., Kandere K., et al. Interleukin-6 and mast cells. Allergy Asthma Proc 23 (2002) 331-335
22. Scabeni S., Lapilla M., Musio S., Gallo B., Ciusani E., Steinman L., et al. CD4 + CD25 + Regulatory T cells specific for a thymus-expressed antigen prevent the development of anaphylaxis to self. J Immunol 180 (2008) 4433-4440
23. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+regulatory T cells. Int Immunol 16 (2004) 249-256
24. Wu K., Bi Y., Sun K., and Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 4 (2007) 269-275